{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:49:44Z","timestamp":1753876184422,"version":"3.41.2"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The use of pulmonary vasodilators for pulmonary arterial hypertension (PAH) has led to a favourable prognosis. In contrast, pulmonary veno-occlusive disease (PVOD) is characterized by the possibility of severe pulmonary oedema after specific PAH therapy. Pulmonary oedema presumably develops in association with pulmonary arterial vasodilation without concomitant pulmonary venodilation. The venous circulation maximally dilates with small amounts of nitroglycerine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 59-year-old woman with advanced PVOD was referred to our hospital. We performed a right heart catheterization after administering combination therapy with selexipag and macitentan, and intravenous nitroglycerine at 0.2 and 0.4\u2005\u03bcg\/kg\/min decreased pulmonary arterial wedge pressure (PAWP) and mean pulmonary arterial pressure (PAP) to minimal levels. The final dose of 1\u2005\u03bcg\/kg\/min yielded an \u223c20% decrease in mean PAP and pulmonary vascular resistance (PVR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Here, we described the acute effect of intravenous nitroglycerine on PAWP and PVR in a patient with PVOD. This case highlights the venodilation response even in advanced PVOD, suggesting the importance of further research into selective venous dilators as potent therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytad365","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T11:58:39Z","timestamp":1691063919000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute venodilation properties of low-dose intravenous nitroglycerine in pulmonary veno-occlusive disease: a case report"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2016-7225","authenticated-orcid":false,"given":"Hidekazu","family":"Maruyama","sequence":"first","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kasumigaura Medical Center , 2-7-14 Shimotakatsu, Tsuchiura, Ibaraki 300-8585 , Japan"},{"name":"Department of Cardiology, Faculty of Medicine, University of Tsukuba , 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577 , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Faculty of Health Science, Tsukuba University of Technology , 4-12-7 Kasuga, Tsukuba, Ibaraki 305-8521 , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kasumigaura Medical Center , 2-7-14 Shimotakatsu, Tsuchiura, Ibaraki 300-8585 , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"2023081107191720400_ytad365-B1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2023081107191720400_ytad365-B2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"2023081107191720400_ytad365-B3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF00874655","article-title":"Difference in nitroglycerin dose-response in the venous and arterial beds","volume":"18","author":"Imhof","year":"1980","journal-title":"Eur J Clin Pharmacol"},{"key":"2023081107191720400_ytad365-B4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1620\/tjem.247.69","article-title":"Beneficial effects of imatinib in a patient with suspected pulmonary veno-occlusive disease","volume":"247","author":"Sato","year":"2019","journal-title":"Tohoku J Exp Med"},{"key":"2023081107191720400_ytad365-B5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"2023081107191720400_ytad365-B6","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.110.981407","article-title":"Nitrate therapy: new aspects concerning molecular action and tolerance","volume":"123","author":"M\u00fcnzel","year":"2011","journal-title":"Circulation"},{"key":"2023081107191720400_ytad365-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2018.02.020","article-title":"Vasodilators in acute heart failure\u2014evidence based on new studies","volume":"51","author":"Travessa","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2023081107191720400_ytad365-B8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2796.2009.02146.x","article-title":"Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study","volume":"267","author":"Breidthardt","year":"2010","journal-title":"J Intern Med"},{"key":"2023081107191720400_ytad365-B9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/01.CIR.0000016641.12984.DC","article-title":"Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"key":"2023081107191720400_ytad365-B10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/S0100-879X2005000200006","article-title":"One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease","volume":"38","author":"Barreto","year":"2005","journal-title":"Braz J Med Biol Res"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytad365\/51037032\/ytad365.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/8\/ytad365\/51095728\/ytad365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/8\/ytad365\/51095728\/ytad365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T07:19:46Z","timestamp":1691738386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytad365\/7236960"}},"subtitle":[],"editor":[{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mapelli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Aiste Monika","family":"Jakstaite","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Alessia","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Megha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytad365","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,8,1]]},"article-number":"ytad365"}}